By Karen Roman Biopharmaceutical company Medera Inc. said it completed patient enrollment for Cohort B of its clinical trial ...

A normal echocardiogram doesn't always mean a healthy heart. Persistent symptoms like breathlessness and fatigue can indicate ...

Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...

China: A multicenter retrospective cohort study from China has identified frailty as a strong and independent predictor of ...

According to a recent study, in heart failure with reduced ejection fraction (HFrEF) patients, elevated high-sensitivity ...

Medera Inc. ('Medera'), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

Background The National Heart Failure Audit gathers data on patients coded at discharge (or death) as having heart failure as ...

A device you might want with you in an avalanche; why heart failure with preserved ejection fraction may be seen as a ...

The year saw the emergence of a new version of an old drug that proved beneficial in patients who have heart failure with ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) ...

In a Liv Hospital study, stem cell therapy improved heart function dramatically using MSCs and EVs, despite a blocked graft.